Cowen and Company’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Cowen and Company’s Portfolio HAIAW Stock Details HAIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-304,108	Closed	-$7.6K	–	540
2024 Q3	$7.6K	Buy	304,108 +3,100	+1%	+$104	﹤0.01%	516
2024 Q2	$12K	Buy	301,008 +100	+0%	+$4	﹤0.01%	443
2024 Q1	$14K	Hold	300,908	–	–	﹤0.01%	478
2023 Q4	$7.58K	Buy	300,908 +257,587	+595%	+$11.3K	﹤0.01%	424
2023 Q3	$1.91K	Sell	43,321 -400	-0.9%	-$25	﹤0.01%	597
2023 Q2	$3.83K	Sell	43,721 -6,473	-13%	-$399	﹤0.01%	486
2023 Q1	$8.08K	Buy	+50,194	New	+$4.85K	﹤0.01%	411

Other funds holding HAIAW

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Cowen and Company's HAIAW Position: Q4 2024 in Review

Cowen and Company sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q4 2024, closing a stake of 304,108 shares — an estimated $7.6K sold.

Cowen and Company first reported a position in HAIAW in Q1 2023 and held it in 7 quarters. The position peaked at $14K in Q1 2024. 3 funds tracked by Wall St. Rank hold HAIAW as of Q4 2024.

Cowen and Company reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q4 2024 after selling out during the quarter.
Cowen and Company sold 304,108 Healthcare AI Acquisition Corp. Warrants shares in Q4 2024, an estimated $7.6K.
Cowen and Company first reported a position in Healthcare AI Acquisition Corp. Warrants in Q1 2023 and held it in 7 quarters.
Cowen and Company's Healthcare AI Acquisition Corp. Warrants position peaked at $14K in Q1 2024.
3 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.